CSF κ-Free light chain index in suspected multiple sclerosis: diagnostic performance vs. Oligoclonal bands and alignment with 2017/2024 McDonald criteria
摘要
The aim of this study was to evaluate the diagnostic value of the cerebrospinal fluid (CSF) κ-free light chain (KFLC) index during initial assessment of suspected multiple sclerosis (MS), compared to CSF restricted oligoclonal bands (OCB) and conventional measures, and to examine the performance of KFLC in the 2017 and 2024 McDonald criteria.
MethodsWe enrolled 112 consecutive individuals referred for suspected MS evaluation. OCB were analyzed in paired serum and CSF samples using isoelectric focusing, followed by immunofixation. KFLC concentrations in serum and CSF were measured with an immunonephelometric assay. For all participants, the 2017 McDonald criteria were applied based on clinical, MRI, and CSF findings.
ResultsAfter evaluation, 64 (57.1%) of participants met the 2017 revision of the McDonald’s criteria. Participants who met the 2017 revision of the McDonald criteria had a statistically significantly higher percentage of CSF-restricted OCBs (96.9% vs. 10.4%, p < 0.001) and a higher KFLC index [46.50 (14.50-133.15) vs. 2.10 (1.73–2.88), p < 0.001] compared to participants who did not fulfill the 2017 revision of the McDonald criteria. KFLC index negatively correlated with age (r=-0.334, p < 0.001). Receiver operating characteristic analysis showed an AUC of 0.965 (95% CI 0.927–1.000, p < 0.001) for the KFLC index to distinguish pwRMS from MS mimics. At the optimal cut-off of 5.60, sensitivity was 90.6%, specificity 95.9%, yielding a Youden’s index J = 0.865.
ConclusionsOur results confirm that the KFLC index is a highly accurate and dependable biomarker for distinguishing MS from non-MS conditions, showing strong concordance with OCBs.